insights_auto
Why is EIKN down 2,81%?
Dive Deeperchevron_right
EIKN:NASDAQ
Eikon Therapeutics Inc
US$7,26
arrow_downward
-2,81%(-0,21) 1D
US$7,26
0,00% (0,00)
bedtimeAfter hours
Closed: 12 ຕ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EIKN...
Open
US$7,45
High
US$7,60
Low
US$7,16
Mkt. cap
393,24 ລ້ານ
Avg. vol.
620,79 ພັນ
Volume
236,19 ພັນ
P/E ratio
0,14
52-wk high
US$17,40
52-wk low
US$7,02
EPS
US$53,57
No. of employees
384
Open
US$7,45
High
US$7,60
Low
US$7,16
Mkt. cap
393,24 ລ້ານ
Avg. vol.
620,79 ພັນ
Volume
236,19 ພັນ
P/E ratio
0,14
52-wk high
US$17,40
52-wk low
US$7,02
EPS
US$53,57
No. of employees
384
News stories
From web sources and news partners
https://www.dars.gov.et/
·
2 ເດືອນກ່ອນ
EIKN Q1 2026 Earnings: Wider-than-Expected Loss as Pre-Revenue Biotech Continues R&D Investment - Analyst Earnings Estimate
About Eikon Therapeutics Inc
CEO-
Employees384
Founded2019
HeadquartersMillbrae, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorBiotechnology
Websiteeikontx.com